Oriola
0.906 EUR +0.67%7,576 investors are following this company
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
P/E (24e)
229.73
EV/EBIT (adj.) (24e)
8.15
P/B (24e)
1.05
Dividend yield-% (24e)
8.83 %
Target price
1.00 EUR
Recommendation
Accumulate
Updated
2.5.2024
NASDAQ Helsinki
OKDBV
Daily low / high price
0.901 / 0.921
EUR
Market cap
164.43M EUR
Turnover
111.05K EUR
Volume
121K
Business risk
Valuation risk
Current
Previous
Analyst
![Rauli Juva Rauli Juva](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://core.inderes.fi/sites/default/files/2023-08/Rauli_Juva.jpg)
Rauli Juva
Analyst
Latest videos
Financial calendar
Interim report
2024-07-18
Interim report
2024-10-30
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Mariatorp Oy | 14.5 % | 13.4 % |
Wipunen varainhallinta oy | 5.0 % | 4.9 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Nina Mähönen | 2023-11-06 | 1,940EUR |
Mikael Nurmi | 2023-11-03 | 9,600EUR |
Premium
This content is for our Premium customers only.
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 1,800.8 | 1,882.4 | 1,841.4 | 1,493.8 | 1,554.7 | 1,626.2 | 1,704.3 | 1,786.1 |
growth-% | 4.6 % | 4.5 % | -2.2 % | -18.9 % | 4.1 % | 4.6 % | 4.8 % | 4.8 % |
EBITDA | 63.1 | 65.4 | 68.6 | 30.1 | 29.2 | 35.9 | 38.4 | 41.8 |
EBIT (adj.) | 21.0 | 26.3 | 34.5 | 16.7 | 19.5 | 23.5 | 25.3 | 27.1 |
EBIT | 20.4 | 20.5 | 40.2 | -5.3 | 17.2 | 23.5 | 25.3 | 27.1 |
Profit before taxes | 14.3 | 14.7 | 35.4 | -17.6 | 0.5 | 18.8 | 24.9 | 26.7 |
Net income | 11.3 | 11.3 | 27.4 | -20.7 | -1.6 | 14.6 | 20.3 | 21.7 |
EPS (adj.) | 0.07 | 0.09 | 0.12 | 0.01 | 0.00 | 0.08 | 0.11 | 0.12 |
growth-% | -9.6 % | 44.4 % | 26.9 % | -94.1 % | -43.7 % | 1,945.7 % | 38.8 % | 7.1 % |
Dividend | 0.03 | 0.04 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.09 |
Dividend ratio | 48.2 % | 64.2 % | 39.7 % | -61.2 % | -915.1 % | 111.6 % | 89.3 % | 75.0 % |
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 3.5 % | 3.5 % | 3.7 % | 2.0 % | 1.9 % | 2.2 % | 2.3 % | 2.3 % |
EBIT-% (adj.) | 1.2 % | 1.4 % | 1.9 % | 1.1 % | 1.3 % | 1.4 % | 1.5 % | 1.5 % |
EBIT-% | 1.1 % | 1.1 % | 2.2 % | -0.4 % | 1.1 % | 1.4 % | 1.5 % | 1.5 % |
ROE | 6.9 % | 5.8 % | 12.4 % | -10.4 % | -1.0 % | 9.3 % | 12.8 % | 13.4 % |
ROI | 5.0 % | 4.6 % | 10.2 % | -3.1 % | 2.8 % | 8.9 % | 11.6 % | 12.9 % |
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 1.90 | 2.01 | 1.74 | 1.09 | 0.91 | 0.91 | 0.91 | 0.91 |
Shares | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 |
Market cap | 344.9 | 363.6 | 315.5 | 197.3 | 164.3 | 164.3 | 164.3 | 164.3 |
Enterprise value | 471.9 | 464.4 | 291.8 | 133.9 | 158.9 | 158.3 | 156.8 | 152.8 |
EV/S | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
EV/EBITDA | 7.5 | 7.1 | 4.3 | 4.4 | 5.4 | 4.4 | 4.1 | 3.7 |
EV/EBIT (adj.) | 22.5 | 17.7 | 8.5 | 8.0 | 8.1 | 6.8 | 6.2 | 5.6 |
EV/EBIT | 23.2 | 22.7 | 7.3 | - | 9.2 | 6.8 | 6.2 | 5.6 |
P/E (adj.) | 29.1 | 21.3 | 14.5 | 155.3 | 229.7 | 11.2 | 8.1 | 7.6 |
P/E | 30.6 | 32.2 | 11.5 | - | - | 11.2 | 8.1 | 7.6 |
P/B | 2.0 | 1.7 | 1.4 | 1.2 | 1.0 | 1.0 | 1.0 | 1.0 |
P/S | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Dividend yield | 1.6 % | 2.0 % | 3.5 % | 6.4 % | 8.8 % | 9.9 % | 11.0 % | 9.9 % |
Equity ratio | 14.5 % | 19.8 % | 23.5 % | 18.3 % | 17.3 % | 16.8 % | 17.3 % | 17.1 % |
Gearing ratio | 74.9 % | 46.5 % | -10.5 % | -12.0 % | -3.4 % | -3.8 % | -4.6 % | -7.0 % |
Quarter data
Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24 | Q2/24e | Q3/24e | Q4/24e | 2024e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 389.0 | 357.9 | 386.5 | 1,493.8 | 375.1 | 403.8 | 374.3 | 401.6 | 1,554.7 |
EBITDA | 6.8 | 7.9 | 8.3 | 30.1 | 6.7 | 8.0 | 7.5 | 7.0 | 29.2 |
EBIT | 3.2 | -17.3 | 5.3 | -5.3 | 3.7 | 5.0 | 4.5 | 4.0 | 17.2 |
Profit before taxes | 1.5 | -19.9 | -0.8 | -17.6 | -2.0 | 1.0 | 1.5 | 0.5 | |
Net income | 1.2 | -20.4 | -2.7 | -20.7 | -2.3 | -0.6 | 0.4 | 1.0 | -1.6 |
ShowingAll content types
Oriola Oyj: Oriola Corporation - Managers' transactions - Närhinen
Oriola Oyj: Oriola Corporation - Managers' transactions - Pärssinen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Oriola Oyj: Oriola Corporation - Managers' transactions - Mähönen
Oriola Oyj: Oriola Corporation - Managers' transactions - Axdorff
Oriola Oyj: Oriola Corporation - Managers' transactions - Westerlund
Oriola Oyj: Oriola Corporation - Managers' transactions - Carlsson Meyer
Oriola Oyj: Oriola Corporation - Managers' transactions - Persdotter Nilsson
Oriola Oyj: The Swedish Competition Authority prohibits Oriola's sale of Svensk dos AB to Apotekstjänst Sverige AB
![Oriola-KD Oyj, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/d1c6d4f8-a86c-4b44-8e2e-b7d901d2b5e6.png)
Oriola-KD Oyj, Q1, 2024
Oriola Oyj: Oriola Corporation's Interim Report January-March 2024
Oriola Oyj: Oriola Corporation to publish its Interim Report for January-March 2024 on 25 April 2024
Oriola Oyj: Oriola Corporation - Managers' transactions - Katarina Gabrielson
![Oriola AGM | CEO's review 19.3.2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/b9f3f4db-5d94-475d-98cf-481ccac78a16.png)
Oriola AGM | CEO's review 19.3.2024
Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors
Oriola Oyj: Oriola Corporation's disposal of own shares based on the share-based incentive plan
Oriola Oyj: Oriola provides restated financial information for the new reporting segments
Oriola Oyj: Oriola Corporation's Annual Report 2023 published
![Oriola Q4'23: Dual Development](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/7b999c6f-14e8-41d4-9c03-78d1d4ac7314.png)